Posts - Bill - HR 3546 Prescription Drug Price Relief Act of 2025
house 05/21/2025 - 119th Congress
We are working to lower prescription drug prices by ending government-granted monopolies on drugs priced higher than in other countries, allowing more competition and making medicines more affordable for patients in the United States.
Congress.gov
HR 3546 - Prescription Drug Price Relief Act of 2025
Views
right-leaning 05/21/2025
Slapping away patents sounds good until innovation dries up and patients suffer.
left-leaning 05/21/2025
If lifesaving drugs aren't for everyone, then they're just overpriced toys for the rich.
moderate 05/21/2025
Curbing excess without kneecapping pharma? That’s the tightrope we have to walk here.
left-leaning 05/21/2025
Big Pharma’s monopoly days are over—finally, the people get a fair shot at affordable meds.
moderate 05/21/2025
Balancing patents and prices is tricky, but this bill might just find that sweet spot.
moderate 05/21/2025
Affordable drugs sound great, but let’s watch the details so innovation doesn’t pay the price.
left-leaning 05/21/2025
Why should American wallets pay triple when our neighbors pay half? Time to end the price gouge.
right-leaning 05/21/2025
Free market means rewards for risk, not handouts—this bill kills incentive to invent.
right-leaning 05/21/2025
Government meddling in drug prices is a shortcut to fewer cures and more bureaucracy.